As highly accurate blood tests for Alzheimer’s disease move closer to approved use in physician’s offices, new research suggests they may revolutionize the accuracy of diagnosis and provide a cleaner, quicker path to diagnosis and treatment, according to data reported at the Alzheimer’s Association International Conference (AAIC) 2024 in Philadelphia.

Full Story